Rani Therapeutics Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Rani Therapeutics Holdings, Inc. (RANI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-30.02-67.88-30.59-53.09-16.70
Depreciation & Amortization1.03-0.220.550.500.59
Stock Based Compensation16.0319.0115.7822.600.00
Change in Working Capital-0.54-0.850.51-3.431.04
Change in Accounts Receivable-0.430.000.000.000.00
Change in Accounts Payable0.71-0.600.160.540.93
Change in Other Working Capital-0.83-1.550.35-1.26-2.43
Other Operating Activities-24.7617.72-31.9923.080.11
Net Cash from Operating Activities-35.50-51.24-46.52-32.25-14.96
Investing Activities
Capital Expenditures-0.271.23-1.620.51-1.20
Purchases of Investments20.0831.09-70.820.000.00
Sales/Maturities of Investments77.5531.093.000.000.00
Other Investing Activities1.250.000.000.000.00
Net Cash from Investing Activities19.8129.86-72.44-0.51-1.20
Financing Activities
Debt Repayment-5.000.000.00-3.310.00
Common Stock Issued18.630.040.3273.650.00
Common Stock Repurchased-0.05-0.16-0.630.000.00
Other Financing Activities-0.050.19-0.26-1.250.16
Net Cash from Financing Activities13.590.2329.0177.1572.68
Summary
Net Change in Cash-2.10-21.14-89.9544.4056.52
Cash at Beginning of Period6.3627.51117.4573.060.00
Cash at End of Period4.266.3627.51117.450.00
Free Cash Flow-35.76-52.47-48.13-32.75-16.16
Supplemental Disclosures
Interest Paid4.114.180.730.290.06
Income Taxes Paid0.000.040.050.070.00